Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 201-220 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 201 | Kurs Orbital lowweak | Opp 2 Risk 1 | Thesis: There is limited relevance support that Kurs Orbital is an operating in-orbit servicing company, which could fit a long-horizon commercial space opportunity framework, but the evidence is only undated directory-style article context rather than direct company-specific positive events or facts. Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain. Evidence
Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided. |
| 202 | Leidos Holdings, Inc. lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Leidos delivered a cloud-based Joint Management Tool to DISA for SATCOM visibility and modernization, suggesting a role in defense SATCOM infrastructure, but no within the recent evidence window evidence are available to support a stronger long-horizon opportunity thesis. Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources. Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics. |
| 203 | LeoLabs, Inc. lowweak | Opp 2 Risk 1 | Thesis: LeoLabs is described in membership rationale as deploying radar for space domain awareness with Space Force/SpaceWERX support, which is strategically relevant, but no available direct evidence support a stronger opportunity call. Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources. Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score. |
| 204 | Leonardo S.p.A. lowweak | Opp 2 Risk 1 | Thesis: Older context suggests strategic optionality from self-funding an Earth-observation constellation of 20 radar and IR imagers, but this evidence is outside the 90-day recent evidence window and therefore insufficient for a strong current ranking. Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis. Evidence
Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence. |
| 205 | Lockheed Martin Corporation lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale references space and defense satellite activity that could support long-term opportunity, but no usable recent evidence window-valid evidence are available here. Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view. |
| 206 | Lux Aeterna lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Lux Aeterna completed a $10 million seed financing and is building a fully reusable satellite platform, which is directionally positive, but the reviewed sources contain no retained within the recent evidence window article evidence or to support a stronger thesis. Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions. Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row. |
| 207 | Lynk Global, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources say Lynk Global was listed as a payload on a Falcon 9 rideshare mission, which hints at tangible space activity and gives slightly more concrete relevance than pure market-list context, but it still does not establish a supported long-horizon opportunity thesis without direct evidence or. Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only. |
| 208 | MBRYONICS Ltd lowweak | Opp 2 Risk 2 | Thesis: There is weak potential opportunity from the reviewed sources' membership rationale that MBRYONICS was a partner on an ESA optical communications project, but the ranking reviewed sources contain no kept direct evidence or citable for that claim. Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation. Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty. |
| 209 | Mercury Systems Inc lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Mercury supplies solid-state data recorders for SDA tracking satellites, which supports space-program exposure, but there are no retained within the recent evidence window evidence to confirm timing, scale, or durability. Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources. Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window. |
| 210 | Meridian Space lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Meridian Space is a broadband constellation for which 280 satellites are being built, which suggests strategic scale potential, but the actual article evidence is not surfaced in the reviewed sources fields used for ranking, so opportunity support is limited. Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields. Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence. |
| 211 | Motiv Space Systems lowweak | Opp 2 Risk 2 | Thesis: Only a weak opportunity case is supported: undated external article-context lists Motiv Space Systems as an operating in-orbit servicing and assembly company, which suggests continued relevance to the sector but does not prove current growth, contracts, or milestones. Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied. Evidence
Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources. |
| 212 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: Membership rationale describes Mynaric as a laser optical communications terminal provider acquired by Rocket Lab, which implies strategic relevance to space communications hardware, but no direct evidence within the recent evidence window are available to support a durable opportunity call. Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here. Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps. |
| 213 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says Mynaric is an acquired laser optical communications company, indicating potentially strategic technology relevance, but there is no direct positive evidence row, quote, or to support a durable opportunity thesis. Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only. |
| 214 | N SPACE TECH lowweak | Opp 2 Risk 2 | Thesis: N SPACE TECH has thematic relevance because the membership rationale profiles it as an Indian aerospace/defense startup designing CubeSats, RF subsystems, radars, and antennas and working with ISRO and DRDO, but the reviewed sources contain no retained 90-day evidence to convert that profile into a current opportunity thesis. Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference. Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity. |
| 215 | Nanoracks lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources includes one external article summary saying NASA awarded Nanoracks a $160 million contract to develop a commercial space station, which is strategically positive if still relevant, but the article is dated September 2, 2025 and was dropped by the 90-day recent evidence window, so support for a current 1 year+ opportunity ranking is weak. Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff. Evidence
Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window. |
| 216 | NordSpace lowweak | Opp 2 Risk 4 | Thesis: Reviewed evidence membership rationale says NordSpace is a private Canadian aerospace/defence startup awarded defense funding for a VLEO satellite concept and planning launches from its own spaceport complex, which would be strategically relevant if current, but no direct evidence or article summaries survived the available recent evidence window in these reviewed sources, so opportunity cannot be ranked highly on evidence alone, unavailable in reviewed sources). Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources. Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources. |
| 217 | NorthStar Earth & Space Inc. lowweak | Opp 2 Risk 4 | Thesis: There is not enough in-window evidence in this specific row to support a strong positive thesis beyond generic cohort relevance. Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources. Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments. |
| 218 | OHB SE lowweak | Opp 2 Risk 2 | Thesis: OHB may have long-horizon opportunity through satellite manufacturing and in-orbit testing infrastructure exposure, as the membership rationale says Mimir 1 was built by OHB Sweden, but there is no retained 90-day evidence in the reviewed sources to support a current ranking catalyst. Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state. Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view. |
| 219 | Optera lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale says Optera received UK space-sector early-stage funding and additional private capital, which could be positive if confirmed, but the current reviewed sources retains no in-window evidence to support a stronger ranking. Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources. Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own. |
| 220 | Paladin Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Paladin Space is partnering to offer debris removal as a service using its Triton payload, which suggests exposure to on-orbit servicing and sustainability themes over a long horizon, but no citeable direct evidence are provided. Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress. Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence. |
Risk view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence in the reviewed sources after recent evidence window, so a material risk thesis is unsupported. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 302 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available. The main risk is that the available evidence is too indirect to establish HEO USA's own operating momentum or strategic durability. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 303 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available, leaving no support for a material risk thesis other than evidence scarcity. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 304 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: No material adverse evidence is shown. Main risk is execution and classification ambiguity rather than documented negative business events. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 305 | Impulso lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available. The only risk is uncertainty from insufficient company-specific information. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 306 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Main risk is evidentiary: there is insufficient recent company-specific evidence in the reviewed sources to validate business progress, customer traction, or execution status. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 307 | Innoseis lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is provided. The main risk is evidentiary: the reviewed sources does not clearly establish business category fit, operating traction, or near-term durability. Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here. |
| 308 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current material adverse thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 309 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis can be supported from retained evidence because the reviewed sources contain no direct negative rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 310 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis can be supported because there is no retained direct negative evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 311 | Intelsat lowweak | Opp 2 Risk 1 | Thesis: There is no material direct negative evidence in the reviewed sources. Main risk is evidence insufficiency rather than a documented adverse business development. Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources. Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness. |
| 312 | iQPS lowweak | Opp 2 Risk 1 | Thesis: No direct adverse evidence is present; the key risk is lack of retained post-recent evidence window evidence confirming launch cadence, financing, or customer demand. Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window. Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence. |
| 313 | Island Green Capital lowweak | Opp 0 Risk 1 | Thesis: No direct adverse event is available, but evidence insufficiency and unresolved identity make it unsuitable for a directional opportunity call. Why now: No timing-based catalyst is supported because no post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: but no were provided in the reviewed sources. Reviewed evidence states summaries were about Molten Ventures and Isar Aerospace rather than clearly about Island Green Capital. Context-only mentions cannot support propagation. |
| 314 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct negative evidence was available inside the 90-day recent evidence window, so there is no supportable adverse thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 315 | Karman Holdings Inc. lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available. The primary risk is that the available context is too generic to prove durable space-specific positioning or a differentiated 1 year+ thesis. Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles. Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence. |
| 316 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is available. The low risk score reflects missing evidence rather than a proven absence of business risk. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 317 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources after recent evidence filtering, but absence of evidence is not evidence of low risk; practical ranking risk is mostly informational opacity. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 318 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no supportable risk thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
| 319 | Kratos Defense & Security Solutions Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources within the recent evidence window, so there is no grounded negative thesis beyond general uncertainty from lack of current evidence. Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources. Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 320 | Kurs Orbital lowweak | Opp 2 Risk 1 | Thesis: Current reviewed sources evidence does not show material adverse developments; the main risk is evidentiary uncertainty rather than a documented company setback. Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain. Evidence
Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided. |